UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050715
Receipt number R000057781
Scientific Title A Retrospective Observational Study to Investigate the Prevalence of NTRK gene fusion positive in Solid Tumor in Japan
Date of disclosure of the study information 2023/04/01
Last modified on 2023/03/29 18:15:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Retrospective Observational Study to Investigate the Prevalence of NTRK gene fusion positive in Solid Tumor in Japan

Acronym

An observational study to learn more about NTRK gene fusion positive in Solid Tumor in Japan

Scientific Title

A Retrospective Observational Study to Investigate the Prevalence of NTRK gene fusion positive in Solid Tumor in Japan

Scientific Title:Acronym

An observational study to learn more about NTRK gene fusion positive in Solid Tumor in Japan

Region

Japan


Condition

Condition

Advanced solid tumor

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

The objective of the study is to investigate the NTRK gene fusions prevalence, co-occurrence with relevant biomarkers/oncogenic drivers, associated fusion partners andcancer types/histology

Basic objectives2

Others

Basic objectives -Others

Prevalence of gene alteration

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prevalence of patients with NTRK gene fusions by patient characteristic categories, such as tumor types.
Distribution of cancer types in patients with NTRK fusion positive among all, adult and pediatric

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with any solid tumor and genome profiling results

Key exclusion criteria

None

Target sample size

50000


Research contact person

Name of lead principal investigator

1st name Tomoyuki
Middle name
Last name Taguchi

Organization

Bayer Yakuhin, Ltd.

Division name

Medical Affairs & Pharmacovigilance

Zip code

100-0005

Address

Marunouchi 1-6-5, Chiyoda-ku, Tokyo, Japan

TEL

080-8525-4319

Email

Tomoyuki.taguchi@bayer.com


Public contact

Name of contact person

1st name Tomoyuki
Middle name
Last name Taguchi

Organization

Bayer Yakuhin, Ltd.

Division name

Medical Affairs & Pharmacovigilance

Zip code

100-0005

Address

Marunouchi 1-6-5, Chiyoda-ku, Tokyo, Japan

TEL

080-8525-4319

Homepage URL


Email

Tomoyuki.taguchi@bayer.com


Sponsor or person

Institute

Bayer Yakuhin, Ltd.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Non-Profit Organization MINS

Address

5-20-9 Mita, Minato City, Tokyo

Tel

03-6416-1868

Email

npo-mins@j-irb.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

46745

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 12 Month 12 Day

Date of IRB

2023 Year 01 Month 13 Day

Anticipated trial start date

2023 Year 02 Month 28 Day

Last follow-up date

2023 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2023 Year 06 Month 30 Day


Other

Other related information

This study will extract the necessary information from the already registered data of subjects who have agreed to be registered with the Center for Cancer Genomics and Advanced Therapeutics (C-CAT) in a secondary manner to evaluate the prevalence of NTRK fusion gene, fusion partner genes with the NTRK gene, and the correlation with other genetic alterations.
Data extraction will be performed by a person authorized to access the portal site designated by C-CAT from the principal investigator's organization, and the data set for analysis will be constructed by the principal investigator's organization. The constructed data set for analysis will be transferred to Syneos Health Clinical, a contractor with whom we have concluded an outsourcing agreement including confidentiality, for analysis. The transferred data set will be promptly destroyed after the completion of the study.
If, between the date of release of this information and June 30, 2023, the scheduled completion date of the study, a registered patient requests refusal of secondary use of the data, such data will not be included in the analysis. In that case, patients may refuse to allow their data to be used in this study by notifying C-CAT through their physician.


Management information

Registered date

2023 Year 03 Month 29 Day

Last modified on

2023 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057781


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name